FGP
EHC icon

Freestone Grove Partners’s Encompass Health EHC Stock Holding History

Freestone Grove Partners’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.7M Buy
382,640
+145,014
+61% +$15M 0.25% 122
2026
Q1 		$23M Buy
237,626
+226,130
+1,967% +$23.2M 0.16% 195
2025
Q4 		$1.22M Sell
11,496
-350,706
-97% -$40.6M 0.01% 445
2025
Q3 		$46M Buy
362,202
+359,763
+14,750% +$42.8M 0.34% 99
2025
Q2 		$299K Sell
2,439
-289,191
-99% -$33M ﹤0.01% 586
2025
Q1 		$29.5M Buy
291,630
+79,695
+38% +$7.78M 0.3% 122
2024
Q4 		$19.6M Buy
+211,935
New +$20.8M 0.24% 139

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Freestone Grove Partners's EHC Position: Q2 2026 in Review

Freestone Grove Partners increased its Encompass Health (EHC) stake by 61% in Q2 2026, buying an estimated $15M and bringing the position to 382,640 shares worth $38.7M. The position accounts for 0.25% of the portfolio, ranked #122.

Freestone Grove Partners first reported a position in EHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $46M in Q3 2025. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Freestone Grove Partners held 382,640 shares of Encompass Health worth $38.7M as of Q2 2026.
  • Freestone Grove Partners bought 145,014 Encompass Health shares in Q2 2026, an estimated $15M.
  • Encompass Health made up 0.25% of Freestone Grove Partners's portfolio in Q2 2026, its #122 holding.
  • Freestone Grove Partners first reported a position in Encompass Health in Q4 2024 and has held it in 7 quarters since.
  • Freestone Grove Partners's Encompass Health position peaked at $46M in Q3 2025.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.